BILL ANALYSIS Ó
SENATE COMMITTEE ON APPROPRIATIONS
Senator Ricardo Lara, Chair
2015 - 2016 Regular Session
SB 423 (Bates) - Retail nonprescription surplus products:
determinations for reuse.
-----------------------------------------------------------------
| |
| |
| |
-----------------------------------------------------------------
|--------------------------------+--------------------------------|
| | |
|Version: July 6, 2015 |Policy Vote: E.Q. 7 - 0 |
| | |
|--------------------------------+--------------------------------|
| | |
|Urgency: Yes |Mandate: Yes |
| | |
|--------------------------------+--------------------------------|
| | |
|Hearing Date: August 27, 2015 |Consultant: Marie Liu |
| | |
-----------------------------------------------------------------
*********** ANALYSIS ADDENDUM - SUSPENSE FILE ***********
The following information is revised to reflect amendments
adopted by the committee on August 27, 2015
Bill
Summary: AB 423 would establish a process for the handling and
management of retail nonprescription pharmaceutical surplus
products.
Fiscal
Impact: Unknown costs to the Hazardous Waste Control Account
(special) for the Department of Toxic Substances Control (DTSC)
to "register" specified entities
Author
Amendments:
Clarify the roles of the Department of Public Health and DTSC
SB 423 (Bates) Page 1 of
?
Specify that a facility that elects to follow the procedures
in this bill are not subject to regulation of specified
products by the Medical Waste Management Act.
-- END --